BioSpace News Archive

Compugen Ltd. Presents New Results Supporting CGEN-15049 As Potential Cancer Immunotherapy Target

February 9, 2015
·
6 min read
Drug Development

Achillion Achieves 100% SVR12 In Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102

February 9, 2015
·
7 min read
Business

Boston Scientific Corporation And C.R. Bard Announce Distribution Agreement For Lutonix Drug Coated Balloon

February 9, 2015
·
5 min read
Business

Immune Pharmaceuticals, Inc. Appoints Paul Nadler, MD, EVP, R&D and Chief Medical Officer

February 9, 2015
·
6 min read
Business

Bill Hoffman Joins Inari Medical As President And Chief Executive Officer

February 9, 2015
·
2 min read
Business

CoLucid Pharmaceuticals, Inc. Appoints Matthew Dallas As Chief Financial Officer And Treasurer

February 9, 2015
·
3 min read
Drug Development

Advanced Inhalation Therapies Receives Orphan Drug Designation Of Its Proprietary High Dose Formulation Of Nitric Oxide For Adjunctive Treatment Of Cystic Fibrosis

February 9, 2015
·
6 min read
Drug Development

Provectus Biopharmaceuticals Inc. Met With FDA On Operational Aspects Of PV-10 Phase 3 Melanoma Study

February 9, 2015
·
1 min read
Drug Development

Bio-Path Holdings, Inc. Starts Phase II Study With Liposomal Grb-2 In AML Patients

February 9, 2015
·
2 min read
Xagenic Hosts CLIA Waiver Panel Discussion At The Molecular Med Tri-Con 2015

February 9, 2015
·
1 min read